Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Sponsor: Encore Medical, L.P.
A observational or N/A phase clinical study on Degenerative Joint Disease and Osteoarthritis, this trial is completed. The trial is conducted by Encore Medical, L.P. and has accumulated 10 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Apr 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Nov 2018 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Feb 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Encore Medical, L.P.
For direct contact, visit the study record on ClinicalTrials.gov .